Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenomics for the treatment of dementia.

Annals of medicine - 1 Jan 2002

Cacabelos Ramón

Abstract excerpt

Alzheimer's disease (AD) is a genetically complex disorder associated with multiple genetic defects either mutational or of susceptibility. Current AD genetics does not explain in full the etiopathogenesis of AD, suggesting that environmental factors and/or epigenetic phenomena may also contribute to AD pathology and phenotypic expression of dementia. The genomics of AD is still in its infancy, but is helping us...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to alpha-Macroglobulins
Share to Alzheimer Disease
Share to Amyloid beta-Protein Precursor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Molecular Epidemiology

Share to Pharmacogenetics

Share to Presenilin-1

Share to Presenilin-2

Share to tau Proteins

Source

Identifiers

PMID: 12452480
DOI: 10.1080/078538902320772115

Genes

APOE
ACE
APP
BCHE
CST3
LRP1
MTHFR
NOS3
TNF

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenomics for the treatment of dementia.PMID 12452480Read ↗

Pharmacogenomics and treatment for dementia induced by Alzheimer's disease.Semantic proximity Read ↗

Pharmacogenomics and therapeutic strategies for dementiaSemantic proximity Read ↗

Pharmacogenetic Considerations in the Treatment of Alzheimer’s DiseaseSemantic proximity Read ↗

Pharmacogenomics in Alzheimer's disease.Semantic proximity Read ↗

Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.Semantic proximity Read ↗

Influence of pharmacogenetic factors on Alzheimer's disease therapeutics.Semantic proximity Read ↗

Opportunities in pharmacogenomics for the treatment of Alzheimer’s diseaseSemantic proximity Read ↗

Novel Therapeutic Strategies for DementiaSemantic proximity Read ↗

Genetics of Alzheimer's disease. A rapidly evolving field.Semantic proximity Read ↗

Pharmacogenomics of Alzheimer’s and Parkinson’s diseasesSemantic proximity Read ↗

Pharmacogenetic Basis for Therapeutic Optimization in Alzheimer’s DiseaseSemantic proximity Read ↗

The application of functional genomics to Alzheimer's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.